Particle.news
Download on the App Store

Oracle and Ci4CC Launch AI Partnership for Cancer Care and Research

The agreement is non-binding with no disclosed financial terms.

Overview

  • The collaboration was announced at the 24th Ci4CC Symposium in Miami Beach, Florida.
  • The partners plan a cancer-optimized electronic health record to address data and workflow hurdles across oncology care.
  • The effort will leverage Ci4CC’s Initiatives Program and its network of NCI-designated and community cancer centers.
  • Priorities include integrating clinical and genomic data, AI-driven clinical trials and drug-development models, and real-world evidence frameworks.
  • Oracle shares traded about 4% lower following the announcement, and no implementation timelines were provided.